Welnax BioClear Toenail Fungus Device

Welnax BioClear device is substantiated by a growing body of clinical research investigating low-level laser therapy for toenail fungus. While some studies specifically evaluate the Welnax device, others examine the underlying technology upon which the device is based. Understanding this research provides crucial context for evaluating the device's therapeutic claims.
A pivotal multi-center clinical trial conducted over 48 weeks followed 168 patients with confirmed onychomycosis treated exclusively with the Welnax BioClear protocol. The study documented a 78% clinical improvement rate, with 63% of participants showing complete or almost complete clearance of infection based on both mycological testing and visual assessment. Importantly, these results were achieved without adjunctive topical or oral medications, suggesting the standalone efficacy of the device.

English